Jamie Matusow, Editor10.01.14
Update: Johnson & Johnson ranks at #10 on our latest report Top 20 Global Beauty Companies 2021.
New Brunswick, NJ
www.jnj.com
Corporate Sales: $28 billion
Beauty Sales: $7.6 billion (Skincare, Baby Care, Oral Products)
Key Personnel: Alex Gorsky, chairman and chief executive officer; Sandra E. Peterson, group worldwide chairman; Lynn Pendergrass, worldwide chairman, consumer; Jesse J. Wu, chairman, Johnson & Johnson China.
Major Products: Johnson’s Baby, Neutrogena, Aveeno, Dabao, Listerine.
New Products: Aveeno Daily Moisturizing Lotion with Broad Spectrum SPF 15, Aveeno Men’s Face Wash, Aveeno Baby Natural Protection Lotion Sunscreen with Broad Spectrum SPF 50; Neutrogena Naturals, Neutrogena MicroMist Airbrush Sunless Tan.
Comments: Johnson & Johnson may be a primarily pharmaceuticals and diagnostics company, but its Consumer division, with just a few key beauty brands, generates enough revenue to swing it into the first quarter of our Top Companies list. The giant corporation that serves more than a billion patients and consumers around the world every day, reported that worldwide sales increased 6.1% to $71.3 billion, compared to increases of 3.4% in 2012 and 5.6% in 2011.
The Consumer segment generated 21% of sales, a gain of 2.8% on an operational basis versus 2012.
In the Consumer category, skincare increased 2.4% and baby care, 1.8%; oral care showed a very slight gain of 0.1%. Skincare sales reached $3.7 billion, largely due to strong results from the Neutrogena, Aveeno and Dabao product lines. Baby Care sales rose to $2.3 billion. Growth was primarily due to sales of hair care and baby cleansers outside the U.S. and newly acquired products from the acquisition of Shanghai Elsker Mother & Baby Co., Ltd.
Like other of our Top Companies, J&J says it has identified specific consumer needs and major brands they think will drive growth, including Neutrogena, Listerine and Johnson’s Baby. The company says it will continue to expand globally with the acquisition of Shanghai Elsker Mother & Baby Co., Ltd, a leading baby care products company in the “naturals” segment, for the Chinese market, as well as its new Johnson’s Baby Triple Baby Protection product line, which is now entering global markets.
Bowing to consumer and regulatory pressures, J&J announced at the start of the year that it had removed formaldehyde from its baby shampoo. Plans are underway to remove the chemical from its entire product line by 2015.
For the first quarter of 2014, consumer product sales fell 3.2% to $3.6 billion; but Aveeno and Dabao skin care sales rose.
In 2013, Jennifer Aniston was named brand ambassador for Aveeno, while Kerry Washington came aboard not only as celebrity brand ambassador, but also as creative consultant for Neutrogena.
In the first half of 2014, corporate sales reached $37.6 billion. Consumer sales fell slightly in the U.S. and rose slightly internationally, for a total of $7.3 billion. Neutrogena, Baby Care and Aveeno were all contributors to the bottom line. Skin care reached $1.9 billion, with a slightly higher split going to the U.S. (rather than worldwide). Baby Care reached $1.2 billion, with the vast majority of sales in international markets.
New Brunswick, NJ
www.jnj.com
Corporate Sales: $28 billion
Beauty Sales: $7.6 billion (Skincare, Baby Care, Oral Products)
Key Personnel: Alex Gorsky, chairman and chief executive officer; Sandra E. Peterson, group worldwide chairman; Lynn Pendergrass, worldwide chairman, consumer; Jesse J. Wu, chairman, Johnson & Johnson China.
Major Products: Johnson’s Baby, Neutrogena, Aveeno, Dabao, Listerine.
New Products: Aveeno Daily Moisturizing Lotion with Broad Spectrum SPF 15, Aveeno Men’s Face Wash, Aveeno Baby Natural Protection Lotion Sunscreen with Broad Spectrum SPF 50; Neutrogena Naturals, Neutrogena MicroMist Airbrush Sunless Tan.
Comments: Johnson & Johnson may be a primarily pharmaceuticals and diagnostics company, but its Consumer division, with just a few key beauty brands, generates enough revenue to swing it into the first quarter of our Top Companies list. The giant corporation that serves more than a billion patients and consumers around the world every day, reported that worldwide sales increased 6.1% to $71.3 billion, compared to increases of 3.4% in 2012 and 5.6% in 2011.
The Consumer segment generated 21% of sales, a gain of 2.8% on an operational basis versus 2012.
In the Consumer category, skincare increased 2.4% and baby care, 1.8%; oral care showed a very slight gain of 0.1%. Skincare sales reached $3.7 billion, largely due to strong results from the Neutrogena, Aveeno and Dabao product lines. Baby Care sales rose to $2.3 billion. Growth was primarily due to sales of hair care and baby cleansers outside the U.S. and newly acquired products from the acquisition of Shanghai Elsker Mother & Baby Co., Ltd.
Like other of our Top Companies, J&J says it has identified specific consumer needs and major brands they think will drive growth, including Neutrogena, Listerine and Johnson’s Baby. The company says it will continue to expand globally with the acquisition of Shanghai Elsker Mother & Baby Co., Ltd, a leading baby care products company in the “naturals” segment, for the Chinese market, as well as its new Johnson’s Baby Triple Baby Protection product line, which is now entering global markets.
Bowing to consumer and regulatory pressures, J&J announced at the start of the year that it had removed formaldehyde from its baby shampoo. Plans are underway to remove the chemical from its entire product line by 2015.
For the first quarter of 2014, consumer product sales fell 3.2% to $3.6 billion; but Aveeno and Dabao skin care sales rose.
In 2013, Jennifer Aniston was named brand ambassador for Aveeno, while Kerry Washington came aboard not only as celebrity brand ambassador, but also as creative consultant for Neutrogena.
In the first half of 2014, corporate sales reached $37.6 billion. Consumer sales fell slightly in the U.S. and rose slightly internationally, for a total of $7.3 billion. Neutrogena, Baby Care and Aveeno were all contributors to the bottom line. Skin care reached $1.9 billion, with a slightly higher split going to the U.S. (rather than worldwide). Baby Care reached $1.2 billion, with the vast majority of sales in international markets.